Sofinnova Partners, società di venture capital leader nel settore delle bioscienze, annuncia il lancio di BiovelocITA
Few, very few, startup acquisitions in 2013. Italians are often bought by foreigners, but is it really necessary to close the market at a national level?
An interview with Silvano Spinelli, the founder of EOS, which, thanks to a promising cancer treatment drug, was sold in the U.S. for a record sum. Project, money, corporate structure, vision: here is how he built the perfect startup. The next dream? Giving a hand in helping a new Italy emerge